CD1D and glioblastoma: Thus, glioblastoma cell lines from CD1d-positive patient glioblastoma samples maintain the status of CD1d expression from original patient tumor tissue, and can be used for the evaluation of iNKT cell-mediated cytotoxicity toward glioblastoma cells.